ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs MXN
16.6998
0.00%
Brent Oil
81.965
0.00%
Bitcoin
69,199.00
0.98%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. NLS Pharmaceutics Ltd (NLSP)

  7. NLS Pharmaceutics Ltd (NLSP) Noticias

NLSP

NLS Pharmaceutics (NLSP)

NLS Pharmaceutics Ltd
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:NLSP
FechaHoraFuenteTítuloSímboloCompañía
11/03/202415:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NLSPNLS Pharmaceutics Ltd
14/06/202307:38Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NLSPNLS Pharmaceutics Ltd
05/05/202315:37Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:NLSPNLS Pharmaceutics Ltd
01/05/202315:31Edgar (US Regulatory)Notification That Form 20-f Will Be Submitted Late (nt 20-f)NASDAQ:NLSPNLS Pharmaceutics Ltd
24/02/202306:56Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NLSPNLS Pharmaceutics Ltd
14/02/202305:10Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NLSPNLS Pharmaceutics Ltd
23/01/202305:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:NLSPNLS Pharmaceutics Ltd
13/01/202315:03Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:NLSPNLS Pharmaceutics Ltd
21/12/202215:03Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:NLSPNLS Pharmaceutics Ltd
16/12/202215:58Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)NASDAQ:NLSPNLS Pharmaceutics Ltd
10/06/202215:44Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1)NASDAQ:NLSPNLS Pharmaceutics Ltd
02/06/202211:15TipRanksBrookline Capital Markets Thinks NLS Pharmaceutics’ Stock is Going to RecoverNASDAQ:NLSPNLS Pharmaceutics Ltd
04/05/202213:25TipRanksBrookline Capital Markets Sticks to Their Buy Rating for NLS Pharmaceutics (NLSP)NASDAQ:NLSPNLS Pharmaceutics Ltd
14/04/202215:49Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NLSPNLS Pharmaceutics Ltd
13/04/202207:18Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:NLSPNLS Pharmaceutics Ltd
17/03/202209:36TipRanksMaxim Group Thinks NLS Pharmaceutics’ Stock is Going to RecoverNASDAQ:NLSPNLS Pharmaceutics Ltd
01/11/202107:31Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)NASDAQ:NLSPNLS Pharmaceutics Ltd
02/06/202107:00PR Newswire (US)NLS Pharmaceutics to Present at the LD Micro Virtual Invitational Conference on June 10, 2021NASDAQ:NLSPNLS Pharmaceutics Ltd
28/05/202107:15PR Newswire (US)NLS Pharmaceutics to Present at The MicroCap Rodeo 2021 Summer Solstice: Best Ideas from the Buyside Conference on June 1NASDAQ:NLSPNLS Pharmaceutics Ltd
27/05/202116:29Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:NLSPNLS Pharmaceutics Ltd
18/05/202107:15PR Newswire (US)NLS Pharmaceutics Announces New Study Data Confirming Mazindol's Unique Orexin Pathway Activation for Treating NarcolepsyNASDAQ:NLSPNLS Pharmaceutics Ltd
05/04/202107:30PR Newswire (US)NLS Pharmaceutics Appoints Silvia Panigone, Ph.D. As Chief Operating OfficerNASDAQ:NLSPNLS Pharmaceutics Ltd
29/03/202107:30PR Newswire (US)NLS Pharmaceutics Announces Issuance of Canadian Patent Covering its Novel Formulation of Controlled-Release Mazindol (Mazind...NASDAQ:NLSPNLS Pharmaceutics Ltd
12/03/202107:00PR Newswire (US)NLS Pharmaceutics Obtains License to Full Regulatory Data Package and Proprietary Know-How for Sanorex® (Mazindol)NASDAQ:NLSPNLS Pharmaceutics Ltd
25/02/202108:00PR Newswire (US)NLS Pharmaceutics to Participate in Upcoming Investor ConferencesNASDAQ:NLSPNLS Pharmaceutics Ltd
02/02/202115:00PR Newswire (US)NLS Pharmaceutics Ltd. Announces Closing of $20.0 Million Initial Public OfferingNASDAQ:NLSPNLS Pharmaceutics Ltd
 Showing the most relevant articles for your search:NASDAQ:NLSP

Su Consulta Reciente

TSX
FCR.UN
First Capital Real Estat...
ASX
RMDKOT
AMEX
FJUL
FT Vest US Equity Buffer...
HUOB
QTUMETH
Qtum
EU
SGEND
Euronext G Engie 261021 ...
NYSE
CCXX
Churchill Capital Corp III
COIN
PBCEUR
USOTC
BNPJY
Banpu Public (PK)
COIN
CAPSBTC
NASDAQ
HLSCX
Hartford Disciplined Equ...
AMEX
LOWV
AB US Low Volatility Equ...
ASX
MAN
Mandrake Resources
LSE
DXJP
Wt Jpn Eq Gbp H
LSE
0HN5
Big Lots
NASDAQ
ABBKXXX
Jpmorgan Chase Bank Na A...
TSXV
VEL
Vanoil Energy Ltd.
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados